HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bidasee, K. R. Articles by Besch, H. R. Search for Related Content PubMed PubMed Citation Articles by Bidasee, K. R. Articles by Besch, H. R. Social Bookmarking                What's this?

Diabetes Increases Formation of Advanced Glycation End Products on Sarco(endo)plasmic Reticulum Ca²⁺-ATPase

¹ Department of Pharmacology, University of Nebraska Medical Center, Omaha, Nebraska
² Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, Indiana
³ Department of Physiology and Biophysics, University of Nebraska Medical Center, Omaha, Nebraska
⁴ Faculty of Pharmacy, University of Ankara, Tandogan, Ankara, Turkey
⁵ Department of Pharmacology and Center for Vascular Biology and Medicine, Indiana University School of Medicine, Indianapolis, Indiana

Prolongation of relaxation is a hallmark of diabetic cardiomyopathy. Most studies attribute this defect to decreases in sarco(endo)plasmic reticulum Ca²⁺-ATPase (SERCA2a) expression and SERCA2a-to-phospholamban (PLB) ratio. Since its turnover rate is slow, SERCA2a is susceptible to posttranslational modifications during diabetes. These modifications could in turn compromise conformational rearrangements needed to translocate calcium ions, also leading to a decrease in SERCA2a activity. In the present study one such modification was investigated, namely advanced glycation end products (AGEs). Hearts from 8-week streptozotocin-induced diabetic (8D) rats showed typical slowing in relaxation, confirming cardiomyopathy. Hearts from 8D animals also expressed lower levels of SERCA2a protein and higher levels of PLB. Analysis of matrix-assisted laser desorption/ionization time-of-flight mass data files from trypsin-digested SERCA2a revealed several cytosolic SERCA2a peptides from 8D modified by single noncrosslinking AGEs. Crosslinked AGEs were also found. Lysine residues within actuator and phosphorylation domains were cross-linked to arginine residues within the nucleotide binding domain via pentosidine AGEs. Two weeks of insulin-treatment initiated after 6 weeks of diabetes attenuated these changes. These data demonstrate for the first time that AGEs are formed on SERCA2a during diabetes, suggesting a novel mechanism by which cardiac relaxation can be slowed during diabetes.

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				D. An and B. Rodrigues Role of changes in cardiac metabolism in development of diabetic cardiomyopathy Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1489 - H1506. [Abstract] [Full Text] [PDF]

				M. B. Johansen, L. Kiemer, and S. Brunak Analysis and prediction of mammalian protein glycation Glycobiology, September 1, 2006; 16(9): 844 - 853. [Abstract] [Full Text] [PDF]

				S. RAHBAR The Discovery of Glycated Hemoglobin: A Major Event in the Study of Nonenzymatic Chemistry in Biological Systems Ann. N.Y. Acad. Sci., June 1, 2005; 1043(1): 9 - 19. [Abstract] [Full Text] [PDF]

				Y. Hu, D. Belke, J. Suarez, E. Swanson, R. Clark, M. Hoshijima, and W. H. Dillmann Adenovirus-Mediated Overexpression of O-GlcNAcase Improves Contractile Function in the Diabetic Heart Circ. Res., May 13, 2005; 96(9): 1006 - 1013. [Abstract] [Full Text] [PDF]